CryptoSlate
Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug
Enlivex pledged commercially reasonable efforts to hold the shareholder vote within 60 days, while the second $400 million remains optional.
Read the full article on CryptoSlate
Opens in a new tab. Cointrackx tracks this click for statistics.
Partner
